为什么长期看好biotech

来源: 三丝 2015-05-01 16:51:50 [] [旧帖] [给我悄悄话] 本文已被阅读: 次 (1194 bytes)
回答: 说几句 Biotech sectorzd3y2015-05-01 15:08:57
Biotech benefits from current laws and policies: within the last decade, the FDA-approval speed has expedited at the unprecedented speed. Last year 40+ drugs were approved. Due to Obama care, a historical high number of 4.3bn of prescription, were filled.
2) Spending on RD in the past decade are becoming fruitful; a numbers of breakthrough bring in promising candidate and promising stocks. When looking at clinical trials gov, use “cancer” as subject, it turned out that only 1974 clinical trials (US) during 1991-2000, and a huge jump to 11652 trials during 2001-2010.
3)Currently basic research results can be quickly translated into therapeutical product candidate. Historical bubble such as genome era companies in 2002 or stem cell companies in 2008-9 already burst because no commercial products were developed.
4)Still the momentum is going on. 2015 Q1 biotech IPO reached 1.7 bn, although less than 2bn from 2014 Q4, and the trend will continue unless the market put a hard brake
5) The improvement of current therapies supports revenue growth year by year. Think about how many people now taking HIV drugs for the rest of their life !

所有跟帖: 

言之有理 -金雕2000- 给 金雕2000 发送悄悄话 (3 bytes) () 05/01/2015 postreply 16:55:49

一个简单的cancer辅序VB17在美加都不让卖,背后是什么原因? -grasshaper- 给 grasshaper 发送悄悄话 (0 bytes) () 05/01/2015 postreply 17:42:56

请您先登陆,再发跟帖!

发现Adblock插件

如要继续浏览
请支持本站 请务必在本站关闭Adblock

关闭Adblock后 请点击

请参考如何关闭Adblock

安装Adblock plus用户请点击浏览器图标
选择“Disable on www.wenxuecity.com”

安装Adblock用户请点击图标
选择“don't run on pages on this domain”